SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10795	Companies
233324	Keywords
161955	Articles
124498	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 07/18/2025 at 07:00, 1 year ago

Press Release: Sanofi completes acquisition of Blueprint Medicines
Sanofi completes acquisition of Blueprint Medicines, adding rare immunology disease medicines to its portfolio. The acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis (SM) and elenestinib for SM, enhancing Sanofi's immunology pipeline

Acquisition Sanofi Immunology Blueprint Medicines Ayvakit/Ayvakyt
BRIEF

published on 07/16/2025 at 07:05, 1 year ago

Sanofi: Fast track designation for SAR446597 in the United States

FDA Gene Therapy Sanofi Macular Degeneration Fast Track
PRESS RELEASE

published on 07/16/2025 at 07:00, 1 year ago

Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
Sanofi's SAR446597 receives fast track designation in the US for geographic atrophy due to age-related macular degeneration, aiming to address unmet medical needs with innovative gene therapy

Gene Therapy Sanofi Fast Track Designation Geographic Atrophy SAR446597
PRESS RELEASE

published on 07/15/2025 at 18:30, 1 year ago

Sanofi: Disclosure of trading in own shares
PRESS RELEASE

published on 06/30/2025 at 21:33, 1 year 1 month ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 06/30/2025 at 07:35, 1 year 1 month ago

Sanofi Releases Q2 2025 Aide Mémoire

Forward-looking Statements Investor Information Financial Modeling Aide Mémoire Sanofi Q2 2025
PRESS RELEASE

published on 06/30/2025 at 07:30, 1 year 1 month ago

Press release: Availability of the Q2 2025 Aide mémoire
Sanofi releases Q2 2025 Aide mémoire for financial modelling, to be published on July 31, 2025. Company details its commitment to innovation and impact in healthcare

Innovation Sanofi Aide Mémoire Financial Modelling Q2 2025
BRIEF

published on 06/25/2025 at 07:05, 1 year 1 month ago

Riliprubart Granted Orphan Drug Designation in the United States

FDA Immunology Orphan Drug Riliprubart Kidney Transplant
PRESS RELEASE

published on 06/25/2025 at 07:00, 1 year 1 month ago

Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation
Sanofi's riliprubart granted orphan drug designation by FDA for antibody-mediated rejection in solid organ transplantation, addressing critical unmet need in transplant medicine

Orphan Drug Designation Sanofi Riliprubart Antibody-mediated Rejection Solid Organ Transplantation
BRIEF

published on 06/23/2025 at 07:05, 1 year 1 month ago

Sarclisa Gains EU Recommendation for Multiple Myeloma Treatment

Multiple Myeloma Phase 3 Study Sarclisa CHMP Approval Induction Therapy

Accesswire

Published on 08/01/2026 at 01:20, 2 days 15 hours ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 15 hours ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 16 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 2 days 16 hours ago

BioNxt Solutions Announces Option Grants
Published on 07/31/2026 at 23:20, 2 days 17 hours ago

Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.

View all ACCESSWIRE

EQS Group

Published on 08/03/2026 at 16:45, 18 minutes ago

Fuller, Smith & Turner PLC: Total Voting Rights, Issue of Shares and Treasury Shares
Published on 08/03/2026 at 16:45, 18 minutes ago

Thailand - Canada Pilot Carbon Capture in Cement Industry to Advance Net Zero 2050
Published on 08/03/2026 at 16:38, 24 minutes ago

BVB Japan Tour 2026: Record Reach, 70,000 Fan Contacts and Strong Commercial Momentum
Published on 08/03/2026 at 16:00, 1 hour 3 minutes ago

Halfords Group PLC: Annual Financial Report
Published on 08/03/2026 at 16:00, 1 hour 3 minutes ago

Shares Admitted to Trading and Total Voting Rights

Les Echos

Published on 08/03/2026 at 10:58, 6 hours 4 minutes ago

GUILLEMOT CORPORATION| Weekly report share buyback from July 27 to July 31 2026
Published on 08/03/2026 at 08:29, 8 hours 34 minutes ago

Launch of a €225 million tranche of its share buyback programme
Published on 08/03/2026 at 07:00, 10 hours 3 minutes ago

BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Published on 07/31/2026 at 21:00, 2 days 20 hours ago

Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 2 days 21 hours ago

Share retention commitments (Dutreil Agreement)

View all LES ECHOS COMFI WIRE